Er Positive Her2 Negative Early Breast Cancer clinical trials

Explore recruiting er positive her2 negative early breast cancer clinical trials.

Recruiting er positive her2 negative early breast cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Er Positive Her2 Negative Early Breast Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NEOadjuvant Abemaciclib and GIredestrant triaL in patients with ER-positive, HER2-negative Early breast cancer

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

IBCSG 67-22 PREcoopERA: A Window-of-Opportunity trial of giredestrant +/- triptorelin vs. anastrozole + triptorelin in premenopausal patients with ER-positive/HER2-negative early breast cancer.

Spain, Germany, Italy, Sweden, Hungary, Ireland +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Er Positive Her2 Negative Early Breast Cancer trials by city

Er Positive Her2 Negative Early Breast Cancer in Toronto Er Positive Her2 Negative Early Breast Cancer in Vancouver Er Positive Her2 Negative Early Breast Cancer in Montreal Er Positive Her2 Negative Early Breast Cancer in Calgary Er Positive Her2 Negative Early Breast Cancer in Edmonton Er Positive Her2 Negative Early Breast Cancer in Ottawa Er Positive Her2 Negative Early Breast Cancer in Winnipeg Er Positive Her2 Negative Early Breast Cancer in Quebec City Er Positive Her2 Negative Early Breast Cancer in Hamilton Er Positive Her2 Negative Early Breast Cancer in Kitchener Er Positive Her2 Negative Early Breast Cancer in London Er Positive Her2 Negative Early Breast Cancer in Halifax Er Positive Her2 Negative Early Breast Cancer in New York Er Positive Her2 Negative Early Breast Cancer in Los Angeles Er Positive Her2 Negative Early Breast Cancer in Chicago Er Positive Her2 Negative Early Breast Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease